Retiform Hemangioendothelioma Developed on the Site of an Earlier Cystic Lymphangioma in a Six-Year-Old Girl

淋巴管瘤 医学 淋巴管瘤病 背景(考古学) 病理 血管内皮瘤 放射科 淋巴系统 生物 古生物学
作者
Anne-Fore Albertini,Nicole Brousse,Christine Bodemer,Eduardo Calonje,Sylvie Fraitag
出处
期刊:American Journal of Dermatopathology [Lippincott Williams & Wilkins]
卷期号:33 (7): e84-e87 被引量:24
标识
DOI:10.1097/dad.0b013e31821b0a9f
摘要

Retiform hemangioendothelioma (RH) is a rare low-grade malignancy angiosarcoma, with a high rate of local recurrence and a low metastatic risk. A 6 year-old girl with a large cervical cystic lymphangioma diagnosed by ultrasound and Doppler ultrasound, which showed a large multiloculated anechoic cyst with no flow. The lymphangioma was treated with injections of Picibanil (OK-432). The tumor regressed, but after a year, she developed a poorly limited infiltrated plaque spreading out regularly over her chest, back, and shoulder. The biopsy showed a poorly limited dermal and subcutaneous vascular proliferation composed of elongated arborising vessels lined with ovoid endothelial cells in a hobnail pattern. In addition, the deep part of the lesion showed typical features of a papillary intralymphatic angioendothelioma pattern (PILA) or Dabska tumor. The endothelial cells strongly expressed podoplanin (D2-40). A diagnosis of RH with focal areas of PILA was reached. The girl died 8 months after surgery of hypovolemic shock in a context of diffuse lymphangiomatosis with pulmonary localization. To our knowledge, RH has hardly ever been described in children. This entity exhibits a continuum with the PILA, sharing not only morphological and immunohistochemical similarities but also its ability to develop in a context of a vascular anomaly, particularly a lymphangioma. The role of Picibanil in the development of this tumor can be discussed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
Zhang完成签到,获得积分10
3秒前
4秒前
5秒前
妙妙发布了新的文献求助10
6秒前
manka发布了新的文献求助10
6秒前
彭于晏应助zz采纳,获得10
7秒前
笑点低的梦槐完成签到 ,获得积分10
8秒前
自由便当完成签到,获得积分10
9秒前
我是老大应助铭铭采纳,获得10
9秒前
9秒前
JJJ完成签到,获得积分10
9秒前
科研通AI2S应助三岁采纳,获得10
10秒前
DXX完成签到,获得积分10
10秒前
10秒前
王三歲完成签到,获得积分10
11秒前
脑洞疼应助叶远望采纳,获得10
12秒前
小二郎应助harri采纳,获得30
12秒前
光亮秋白完成签到,获得积分10
12秒前
聪明牛排发布了新的文献求助20
13秒前
Xu思語完成签到 ,获得积分10
15秒前
16秒前
16秒前
米米完成签到 ,获得积分10
17秒前
昵称完成签到,获得积分10
17秒前
18秒前
落寞的寒云完成签到,获得积分20
18秒前
21秒前
识字岭的岭应助moodys采纳,获得10
21秒前
认真飞瑶发布了新的文献求助10
22秒前
22秒前
风中怜晴完成签到,获得积分10
23秒前
漂亮思菱发布了新的文献求助10
23秒前
潇洒念波完成签到,获得积分10
24秒前
Hero完成签到,获得积分10
25秒前
萧瑟处完成签到,获得积分10
25秒前
Hero发布了新的文献求助10
28秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Cronologia da história de Macau 1600
Developmental Peace: Theorizing China’s Approach to International Peacebuilding 1000
Traitements Prothétiques et Implantaires de l'Édenté total 2.0 1000
Earth System Geophysics 1000
Bioseparations Science and Engineering Third Edition 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6131771
求助须知:如何正确求助?哪些是违规求助? 7959199
关于积分的说明 16516151
捐赠科研通 5248884
什么是DOI,文献DOI怎么找? 2803038
邀请新用户注册赠送积分活动 1784064
关于科研通互助平台的介绍 1655150